Inventor
TRABANCO-SUÁREZ ANDRÉS AVELINO
ES23 patents
⚠️ This page may combine multiple inventors who share the name “TRABANCO-SUÁREZ ANDRÉS AVELINO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
14 patentsUS10005786B2Jun 26, 2018
Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of MGLUR2 receptors
JANSSEN PHARMACEUTICA NV3 citations71
US9708315B2Jul 18, 2017
1,2,4-triazolo[4,3-a]pyridine compounds and their use as positive allosteric modulators of MGLUR2 receptors
JANSSEN PHARMACEUTICA NV5 citations69
US10537573B2Jan 21, 2020
Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
JANSSEN PHARMACEUTICA NV1 citations68
US12048696B2Jul 30, 2024
Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
JANSSEN PHARMACEUTICA NV0 citations57
US11369606B2Jun 28, 2022
Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
JANSSEN PHARMACEUTICA NV1 citations57
US11103506B2Aug 31, 2021
Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
JANSSEN PHARMACEUTICA NV0 citations57
US10512646B2Dec 24, 2019
Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of mGluR2 receptors
JANSSEN PHARMACEUTICA NV0 citations50
US10112949B2Oct 30, 2018
6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one compounds and their use as negative allosteric modulators of mGluR2 receptors
JANSSEN PHARMACEUTICA NV1 citations50
US10519162B2Dec 31, 2019
6,7-dihydropyrazolo[1,5-α]pyrazin-4(5H)-one compounds and their use as negative allosteric modulators of mGluR2 receptors
JANSSEN PHARMACEUTICA NV0 citations49
US10005785B2Jun 26, 2018
Substituted 6,7-dihydropyrazolo[1,5-a] pyrazines as negative allosteric modulators of mGlUR2 receptors
JANSSEN PHARMACEUTICA NV1 citations49
US9828350B2Nov 28, 2017
5,6-dihydro-2H-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (BACE)
JANSSEN PHARMACEUTICA NV1 citations49
US10584129B2Mar 10, 2020
Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of mGluR2 receptors
JANSSEN PHARMACEUTICA NV0 citations47
US10106542B2Oct 23, 2018
Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of mGluR2 receptors
JANSSEN PHARMACEUTICA NV1 citations47
US10106524B2Oct 23, 2018
2,3,4,5-tetrahydropyridin-6-amine and 3,4-dihydro-2H-pyrrol-5-amine compound inhibitors of beta-secretase
JANSSEN PHARMACEUTICA NV1 citations47
CID-NÚÑEZ JOSÉ MARIA
3 patentsUS9012448B2Apr 21, 2015
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
CID-NÚÑEZ JOSÉ MARIA17 citations81
US9271967B2Mar 1, 2016
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
CID-NÚÑEZ JOSÉ MARIA4 citations70
US8993591B2Mar 31, 2015
1,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
CID-NÚÑEZ JOSÉ MARIA4 citations70
TRABANCO-SUÁREZ ANDRÉS AVELINO
3 patentsUS9840507B2Dec 12, 2017
5,6-dihydro-imidazo[1,2-a]pyrazin-8-ylamine derivatives useful as inhibitors of beta-secretase (BACE)
TRABANCO-SUÁREZ ANDRÉS AVELINO0 citations34
US9346811B2May 24, 2016
6,7-dihydro-pyrazolo[1,5-a]pyrazin-4-ylamine derivatives useful as inhibitors of beta-secretase (BACE)
TRABANCO-SUÁREZ ANDRÉS AVELINO0 citations34
US9845326B2Dec 19, 2017
Substituted 3,4-dihydropyrrolo[1,2-A]pyrazines as beta-secretase (BACE) inhibitors
TRABANCO-SUÁREZ ANDRÉS AVELINO0 citations30